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Abstract 
Neurocysticercosis, involvement of the central nervous system by taenia solium, is one of 
the most common parasitic diseases of the CNS. However, spinal involvement by neu-
rocysticercosis is uncommon. Here, we reported a 40-year-old woman with intramedul-
lary cysticercosis in the thoracic spinal cord. MRI revealed two well-defined round in-
tramedullary  lesions  at  T4  and  T5  vertebral  levels,  which  were  homogeneously  hy-
pointense on T1WI and hyperintense on T2WI with peripheral edema. Since the patient 
had progressive neurological deficits, surgery was performed to decompress the spinal 
cord. Histopathology examination of the removed lesion proved it was intramedullary 
cysticercosis. In this report, we also discussed the principles of diagnosis and treatment 
of intramedullary cysticercosis in combination of literature review. 
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Introduction 
Neurocysticercosis, caused by Taenia solium, is 
the  most  common  parasitic  infection  affecting  the 
central  nervous  system.  However,  the  spinal  cysti-
cercosis is rare, representing 1.2% to 5.8% of all cases 
of neurocysticercosis19, 20. According to the cysticercus 
location  in  spine,  Cysticercosis  has  been  classified 
anatomically as extraspinal (vertebral) or intraspinal 
(epidural, subdural, arachnoid, or intramedullary), of 
which the intramedullary type is quite rare and only 
fifty-three cases have been reported until 20101-3,8,13. 
Here, we reported a case of intramedullary cysticer-
cosis at T4 and T5 vertebral level and discussed its 
diagnosis and treatment with literature review.  
Case Report 
A 40-year-old female patient was transferred to 
our department from a local hospital for progressive 
weakness in both lower limbs for one month, and anal 
sphincter  and  bladder  dysfunction  for  two  days. 
Neurological examination disclosed spastic parapare-
sis with decreased motor power of grade 3/5 in both 
lower  limbs,  impaired  sensations  below  T4  derma-
tome, brisk tendon jerks and positive Babinski signs 
on  both  sides.  Non-contrast  MRI  revealed  two 
well-defined round intramedullary cystic lesions at T4 
and T5 vertebral levels, which were homogeneously 
hypointense on T1WI and hyperintense on T2WI with 
slightly  peripheral  edema.  The  subarachnoid  space 
from T4 to T5 was narrow due to the marked expan-
sion of spinal cord. There were no abnormalities at 
cervical or lumbar levels or within the brain paren-
chyma. The diagnosis of intramedullary mass lesion 
was made. There is no use of dexamethasone in the 
perioperative period. 
The patient underwent laminectomy from T4 to 
T5, and the spinal cord was found swollen. When a 
midline  myelotomy  was  performed,  a  white  cystic 
lesion was seen and clear fluid was then aspirated. 
The  cyst  wall  of  which  slightly  stuck  to  the  sur-
rounding spinal cord. In order to dissect the cyst with 
minimal injury to the peripheral tissue, the cystic liq-
uid was partly withdrawn first and the slackened cyst 
was removed totally. The liquid was yellowish and 
transparent. Histological examination of the resected 
sample showed cysticercosis. 
Postoperatively, the patient refused to be treated 
with anticysticercal agents and steroids. The patient's 
neurological  function  postoperatively  was  not  un-
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changed from his preoperatively status and she was 
discharged 2 weeks later. At six months of follow-up, 
the  motor  power  of  her  lower  limbs  recovered  to 
grade 4/5, and she could ambulate without special 
support. The function of anal sphincter and bladder 
regained without compromise of the activities of her 
daily living. However, her hypoesthesia over the T4 
dermatome still existed.  
 
           
Figure 1. Sagittal T1, T2-weighted MR image of thoracic spine showing a relatively well defined cystic intramedullary 
lesion with hypointense on T1WI and hyperintense on T2WI. 
 
 
Figure 2. Photomicrographs of the histological specimen showing the cysticercosis cyst wall with neutrophile gran-
ulocyte.lymphocyte and necrosis cell. (H&E×100) 
 
Discussion  
Cysticercosis is widely endemic in Brazil, Peru, 
Mexico,  Korea  and  India19-20.  Intramedullary  cysti-
cercosis often presents in the patients between 20 to 45 
years old, with the youngest one 5 years old and the 
oldest one 45 year’s old15. Most patients experienced a 
progressively  worsened  course  from  a  week  to  10 
years20. The common clinical manifestations included 
pain,  paraparesis,  spasticity,  bowel  and  bladder  in-
continence, and sexual dysfunction1,20. However, in-
flammatory reaction against the dead parasite is as-
sociated with perilesional edema, which can damage 
medullar  parenchyma  and  therefore,  worsen  symp-
toms2. Inside the spinal cord, cysticercus usually dis-
tributes in the thoracic cord, with a few cases involv-
ing the cervical and the lumbar cord. This distribu-
tional  mode  of  cysticercus  supports  the  hypothesis 
that intramedullary cysticercus comes from the blood 
circulation,  because  thoracic  cord  has  much  more 
blood  supply  than  the  other  parts  of  the  spinal 
cord6,20. However, it is also thought that intramedul-
lary cysticercus could migrate to the spinal cord via 
the  ventriculo-ependymal  pathway.  On  MRI,  in-
tramedullary  cysticercosis  usually  show  a  cystic  le-
sion  within  the  spinal  cord,  which  of  appears  hy-Int. J. Med. Sci. 2011, 8 
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pointense on T1WI with hyperintense scolex identi-
fied inside the cyst cavity, hyperintense on T2WI in 
vesicular  stage,  a  subtle  hypointense  rim  may  sur-
round the intramedullary cyst on T2WI. In the col-
loidal stage the thickened cyst capsule is hyperintense 
on T1WI and hypointense on the T2WI. Cyst contents 
appear  hyperintense  on  T1WI  resulting  in  scolex  is 
not seen. There is an amount of surrounding edema. If 
cyst  degeneration  is  present  peripheral  ring  en-
hancement may be present1,2,15,17. The differential di-
agnosis of an intramedullary cystic lesion is extensive, 
including some other cysts such as arachnoid cyst14, 
ependymal  cyst10,  neurenteric  cyst18,  sarcoidosis4, 
neoplasms such as ependymoma, and infections such 
as abscess21. 
When a patient had a history of cysticercosis or 
came  from  an  endemic  region  and  MRI  revealed  a 
cystic spinal cord lesion, the diagnosis of intramedul-
lary cysticercosis could be suspected and be further 
verified  by  serologic  alterations,  subcutaneous  nod-
ules, and changes in the cerebrospinal fluid. The CSF 
examination often shows increased proteins, a low or 
normal  glucose,  moderate  lymphocytic  pleocytosis 
and eosinophilia7. Cysticercal antibodies found in CSF 
either by ELISA or in serum by enzyme-linked im-
munoelectric transfer bolt assay have good sensitivity 
and specificity in cysticercosis diagnosis7,22. However, 
the  patient  lacked  of  neurocysticercosis  history and 
was  not  from  an  endemic  region.  Therefore,  it  was 
difficult to clinically suspect intramedullary cysticer-
cosis prior to treatment. The diagnosis of neurocysti-
cercosis  was  established  based  on  pathological  ex-
amination. In our case, owing to increasing neurolog-
ical  deficit,  surgical  treatment  is  a  good  choice  for 
removing the mass which produces progressive spi-
nal compression and confirm the diagnosis. Our pa-
tient  showed  improvement  in  motor  power.  Bowel 
movements and urinary sphincters was better control. 
However, the results of surgical outcome are mixed. 
Mohanty16 reported only a 75% satisfactory outcome 
after surgery and cysticidal treatment. Early diagnosis 
and treatment can improve the outcome. Outcomes 
reported  in  other  series  have  not  been  favorable. 
Sharma1  reported  that  60%  patients  acquired  im-
provement after surgery, 25% did not improve, and 
15%  died.  In  the  reports  published  in  recent  years 
1,2,9,12,15, surgical outcome was significantly improved; 
no death case and majority of patients could live a life 
without  special  support.  Surgery  is  procedure  of 
choice  only  when  diagnosis  is  in  doubt  otherwise 
medical treatment has its advantages. Albendazole is 
a medicine that has been proved to be effective in the 
patients with intramedullary cysticercosis since 19965. 
Preoperative adjunctive treatment with albendazole is 
thought  to  be  helpful  to  consolidate  the  lesion  and 
thus induce a clear plane of dissection during surgery. 
Albendazole  is  normally  used  postoperatively  as  a 
regular treatment (15mg/kg/day) for 4 to 6 weeks, 
according to the idea that cysticercosis is a general-
ized disease with focal manifestation. Moreover, Al-
bendazole is often used with corticosteroids, because 
its blood level could be synergistically increased by 
the  latter11.  Except  for  being  used  after  surgery, 
Abendazole also could be used independently in the 
conservative  treatment  for  the  patients  whom  are 
highly suspected as intramedullary cysticercosis and 
whose  clinical  courses  are  stable.  The  potential  ad-
vantages of medical therapy alone include avoidance 
of  surgery  and  treatment  of  surgically  unreachable 
and multifocal cysticercus2,3,5,7,17.  
Conclusions 
In conclusion, we think that intramedullary cys-
ticercosis represents a diagnostic challenge and neu-
rocysticercosis should also be strongly considered for 
intramedullary cystic lesions, even in a non-endemic 
area. Surgery is required to facilitate extirpation of the 
lesion, decompress the cord, confirm the pathological 
diagnosis and provide a route for definitive therapy. 
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